LCTX Operating Income Growth
Lineage Cell Therapeutics, Inc. Common Stock · Operating Income Growth
LCTX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported23.80%period ending
LCTX TTM Operating Income YoY % (-20.00% → 23.80%)
Year-over-year change
High-resolution chart · PNG
LCTX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 23.7974% | |
| -76.8455% | |
| -70.4954% | |
| -54.7778% | |
| -37.6636% | |
| 13.8575% | |
| 13.1606% | |
| 9.1164% | |
| -8.656% | |
| -8.7235% | |
| -9.8268% | |
| 43.3124% | |
| 48.4675% | |
| 53.1149% | |
| 54.2379% | |
| -64.286% | |
| -70.9653% | |
| -86.3349% | |
| -86.074% | |
| 2.1212% | |
| 8.2275% | |
| 22.3348% | |
| 31.9709% | |
| 34.846% | |
| 33.8555% | |
| 20.8077% | |
| 6.9841% | |
| -2.0848% | |
| -9.0059% | |
| -1.8951% | |
| -2.8016% | |
| 2.5858% | |
| 4.6735% | |
| 10.5265% | |
| 31.0553% | |
| 38.9968% | |
| 44.9256% | |
| 38.8979% | |
| 10.3842% | |
| -18.6464% | |
| -43.7518% | |
| -43.2196% | |
| -29.6804% | |
| 10.8546% | |
| 15.9427% | |
| 9.6065% | |
| 9.3765% | |
| -94.4226% | |
| -115.9058% | |
| -113.9142% | |
| -123.9691% | |
| -44.2489% | |
| -36.029% | |
| -158.4337% | |
| -186.1205% | |
| -232.7748% | |
| -312.4959% | |
| 15.3488% | |
| 11.333% | |
| -61.0911% | |
| -8.5827% | |
| -245.435% | |
| -206.0901% | |
| 26.2758% | |
| -24.1301% | |
| 2.8911% | |
| 0.5831% | |
| -134.2593% | |
| -120.4492% | |
| -235.9694% | |
| -164.8923% | |
| -93.6576% | |
| -21.276% | |
| 38.3351% | |
| 30.2177% | |
| 30.342% | |
| 25.8602% | |
| -2.9914% | |
| 13.2058% | |
| 13.0822% | |
| 9.2281% | |
| 19.8668% | |
| -2.5213% | |
| -23.6572% | |
| -28.6885% | |
| -26.5465% | |
| -16.5074% | |
| 9.4307% | |
| 10.6326% | |
| 12.0028% | |
| 16.9466% | |
| -3.5659% | |
| 23.8351% | |
| 35.0705% | |
| 41.037% | |
| 54.1995% | |
| 43.8708% | |
| 35.0808% | |
| 32.2103% | |
| 26.3467% |